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Cancer incidence is rising across the world. Up-to-date
statistics on cancer occurrence and outcome are
essential for the planning and evaluation of programmes
for cancer control. In Pakistan we do not have a National
Cancer Registry. Data is being published on the South
Karachi cancer cases. The age-standardized rates
(ASR) for cancer (whole body sites), during 1995 to
1997 in Karachi South were 139.11/100,000 in males
and 169.5/100,000 in females. Corresponding rates for
the period 1998 to 2002 were 179.0/100,000 in males
and 204.1/100,000 in females. In the 1995-1997 data,
the most common malignancies (ASR per 100,000) in
males were lung (21.3), oral cavity (14.2), urinary
bladder (9.0), and larynx (8.8). The most frequent
cancers in females were breast (53.1%), oral cavity
(14.5%), and ovary (10.9%). The data from 1998 to
2002 showed a rising incidence for lung (25.5%), larynx
(11.8%), and urinary bladder (9.9%) in males and breast
(69.1%), esophagus (8.6%), and cervix (8.6%) in
females. The mean age of cancer all sites was 51.2
years (95% CI 49.4-53.1) for males; 50.0 years (95% CI
48.2-52.4) for females in 1995-1997. Corresponding
rates for 1998-2002 were 49.5 years (95%CI 47.5-51.4)
in males and 53.7 years (95% CI 51.5-55.6) in females.1
Some institutions are now starting to develop their own
Cancer Registry.
The global cancer incidence estimate by the GLOBOCAN
2002 was 8.7% (men 13.3%; women 3.4%) under-
estimated due to under-ascertainment in elderly cases.
This means that worldwide, new cancer cases in 2002
were 11,810,000 (6,574,000 men; 5,236,000 women),
overtaking the original estimate by 1 million.2
The crude annual incidence of cancer in Europe has
been estimated at 338 per 100,000 population for
Eastern Europe and 447 per 100,000 population in
Western Europe.3 Each year more than 284,000 people
are diagnosed with cancer (excluding non-melanoma
skin cancer) in the UK, and more than 1 in 3 people will
develop some form of cancer during their lifetime.4
In Europe, the relevant information for 2008 is not
generally available as yet, therefore, statistical models
based on published data were used to estimate
incidence and mortality data for 25 cancers in 40
European countries (grouped and individually) in 2008.
If not collected, national rates were estimated from
national mortality data and incidence and mortality data
provided by local cancer registries of the same or
neighbouring country. There were an estimated 3.2
million new cases of cancer and 1.7 million deaths from
cancer in 2008.5
Despite the lack of a Registry and population-based
data on demographics and characteristics of various
cancers, this fact is being observed by practicing
clinicians that now they are diagnosing more
malignancies in their clinics than ever before. One of the
typical prototype example is squamous cell carcinoma
of the head and neck region which is found to be
associated with the use of tobacco in the form of beetle
leaf, beetle nuts, various forms of chewing tobaccos,
gutkas and a combination of some or all of these harmful
substances.
As rising cancer incidence is a global issue, and some
cancers are preventable, health policy makers in certain
countries took the issue as a national priority. Countries
like USA, UK, France, and others had made their
National Cancer Plans, and they are in the process of
implementing their goals and objectives.
We in Pakistan are still struggling to develop these
strategies. Being a developing country we cannot afford
to provide state-of-the-art treatment facilities to the
patients. The overall expenses of cancer management
are huge and lack of resources is a major factor, which
plays a vitally important role in the poor outcome of this
disease in our country. Patients present late, and by the
time their tumours are diagnosed, they can only be
considered for palliative treatment.
With the above mentioned suboptimal starting point,
there is another issue of treatment. Other countries of
the world had learnt the hard lessons and now they have
realized that cancer management is not a one man
show. It is of the highest importance and relevance to
involve key stake holders in the form of all concerned
specialties before embarking on a comprehensive
management plan for a particular patient. Working in a
world where the working week and the available
qualified staff are both shrinking, a continuous provision
of good quality care and clinical services is only possible
with multidisciplinary team work. 
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EDITORIAL
Being looked after by a multidisciplinary team, the
patient’s faith and confidence increases markedly just
as an assurance of not being treated by a single
clinician.
The UK Cancer Plan set out the first comprehensive
national cancer programme for England. It had four
aims, which were centered around tackling health
inequalities in order to get down the death toll of the
unskilled workers, who were twice as likely to die of
cancer as compared to the professionals. They invested
into strong cancer research and genetics, to save more
lives, ensuring provision of the best available support,
care and treatment to all the cancer patients. This plan
provided a strategy for bringing together prevention,
screening, diagnosis, treatment and care for cancer and
the investment needed to deliver these services in terms
of improved staffing, equipment, drugs, treatments and
information systems.6
There is a growing tendency amongst members of the
oncology community to form Expert Panel Multi
Disciplinary Tumour Boards and to discuss all cases in
this panel before offering the treatment to the patient.
As this is a recommended international approach,
specialists are quite willing to adopt this culture of
sharing ideas with their colleagues. An evidence of
multidisciplinary approaches providing optimal treatment
outcome for locally advanced head and neck cancer,
with overall survival in these patients being comparable
to that reported in randomized clinical trials was
reported by Nguyen et al. in their retrospective analysis
of 213 patients treated for locally advanced head and
neck cancer in a single institution.7 This effective clinical
approach will provide opportunities to individual
members of the team to speak directly to each other
about clinical matters, discussing the often forgotten
clinical management protocols, thus enhancing their
quality of care and outcome.
Unfortunately, no institute so far, has made arrangement
to discuss all newly diagnosed cancer patients in their
Tumour Boards. In my opinion, no cancer patient should
be treated without making a comprehensive manage-
ment plan which has to be agreed upon by consensus in
an Expert Panel Multi-Disciplinary Tumour Board. The
core constituents of a Tumour Board are Oncologists,
Surgeons, Radiologists, Pathologists and Physicians.
Other members from the support services can also
participate e.g. Nutritionists, etc. Postgraduate trainee
doctors can learn and develop valuable clinical skills
while attending the Boards. This is an easy access to
knowledge, where case discussions lead to a cross
fertilisation of ideas that may not have been apparent to
a single treating clinician. Team working increases the
sense of partnership and provides friendship and
support particularly in difficult clinical situations such as
the management of clinical errors and complaints. An
effective arguing for resource management can duly be
addressed.
It is high time for all the Pakistani speacialists involved
in the care and management of cancer patients to come
forward and establish these boards both in private and
public sector hospitals. 
Hopefully, we would go through the same flux, and after
initial teething problems, non-oncology colleagues can
be convinced to come forward and help in the formation
of these team meetings, which can be conducted on a
regular basis with a view of discussing all the newly
diagnosed cases of cancer.
Keeping the above mentioned facts in view, some
consultant colleagues across the country are trying to
spare their times from busy academic and clinical
commitments for the Tumour Boards but more compre-
hensive and generalized efforts are required in order to
achieve a 100% coverage. All teaching hospitals in
Pakistan have the vision of establishing these tumour
boards in their institutes. Some have already started and
some are in the process of establishing them. The Aga
Khan University Hospital, Karachi, is a tertiary referral
teaching hospital where a Friday morning weekly
tumour board is taking place since last many years.
Specialist colleagues from almost all major hospitals in
Karachi attend this tumour board and present and give
their independent expert opinions on complex cancer
cases . Site-specific tumour boards, e.g. Breast, Head
and Neck, Orthopaedics, Gynaecology, Paediatrics,
Thyroid, etc. are being established as well. The final
outcome is documented in the patients’ case notes.
During the Board meetings postgraduate trainees
present the cases and according to our experience, that
serves as the best form of their structured training as
they openly discuss cases and learn how to tackle
difference of opinion. Multi-disciplinary presence gives a
sense of team ownership of the cancer patients. At this
point it is important to clarify that cases of other
hospitals are also welcomed here and our colleagues
working elsewhere are also given the opportunity to
present and discuss their cases. These mutual sessions
have lead to fruitful decisions, benefiting patients and
saving cost and time.
Such tumour boards have also been started at some
other public hospitals but the need is to spread the
practice to encompass the whole spectrum of new
cancer cases as much as possible.
REFERENCES
1. Bhurgri Y, Bhurgri A, Nishter S, Ahmed A, Usman A, Pervez S,
et al. Pakistan--country profile of cancer and cancer control
1995-2004. J Pak Med Assoc 2006; 56:124-30.
2. Fallah M, Kharazmi E. Global cancer incidences are
260 Journal of the College of Physicians and Surgeons Pakistan  2011, Vol. 21 (5): 259-261
Ahmed Nadeem Abbasi
substantially under-estimated due to under-ascertainment in
elderly cancer cases. Asian Pac J Cancer Prev 2009; 10:223-6.
3. WHO. International Agency for Research on Cancer. About cancer
mondial [Internet]. [updated 2004]. Available from: http://www.dep.iarc.fr/
4. Quinn MBP, Kirby L, Brock A. Registrations of cancer diagnosed
in 1994-1997, England: Office for National Statistics; 2000.
5. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer
incidence and mortality in Europe in 2008. Eur J Cancer 2010;
46:765-81.
6. Department of Health. The NHS cancer plan: a plan for
investment a plan for reform. London: Crown Copyright;
2000. 
7. Nguyen NP, Vos P, Lee H, Borok TL, Karlsson U, Martinez T,
et al. Impact of tumour board recommendations on treatment
Journal of the College of Physicians and Surgeons Pakistan  2011, Vol. 21 (5): 259-261  261
Cancer management is a multidisciplinary team work
l l l l lOl l l l l
